Page 187 - Read Online
P. 187

Koseki et al.                                                                                                                                                             Inflammatory cells in intracranial aneurysm

           agent.  Hence, if such a kind of contrast agent can be   A, Torner J, Derdeyn C, Raabe A, Mocco J, Korja M, Abdulazim A,
                 [56]
           developed for clinical usage, rupture-prone IAs could   Amin-Hanjani S, Al-Shahi Salman R, Barrow D, Bederson J, Bonafe A,
           presumably be differentiated from stable lesions.     Dumont A, Fiorella D, Gruber A, Hankey G, Hasan D, Hoh B, Jabbour
                                                                 P, Kasuya H, Kelly M, Kirkpatrick P, Knuckey N, Koivisto T, Krings T,
                                                                 Lawton M, Marotta T, Mayer S, Mee E, Pereira V, Molyneux A, Morgan
           CONCLUSION                                            M, Mori K, Murayama Y, Nagahiro S, Nakayama N, Niemelä M, Ogilvy
                                                                 C, Pierot L, Rabinstein A, Roos Y, Rinne J, Rosenwasser R, Ronkainen
           The accumulation of histopathological and experimental   A, Schaller K, Seifert V, Solomon R, Spears J, Steiger H, Vergouwen
           evidence from human IA specimens and animal IA        M, Wanke I, Wermer M, Wong G, Wong J, Zipfel G, Connolly EJ,
           models  has  significantly  promoted  the  conceptual   Steinmetz  H,  Lanzino  G,  Pasqualin  A,  Rüfenacht  D,  Vajkoczy  P,
           understanding of the pathogenesis of IA and has       McDougall C, Hänggi  D,  LeRoux  P,  Rinkel  G, Macdonald  R.  The
                                                                 unruptured intracranial aneurysm treatment score: a multidisciplinary
           defined  IA  as  a  macrophage-mediated  chronic      consensus. Neurology 2015;85:881-9.
           inflammatory disease of the arterial walls. This recent   6.   Greving JP, Wermer MJ, Brown RD Jr., Morita A, Juvela S, Yonekura M,
           advancement in the understanding of IA pathogenesis   Ishibashi T, Torner JC, Nakayama T, Rinkel GJ, Algra A. Development
           greatly encourages the development of not only novel   of the PHASES score for prediction of risk of rupture of intracranial
           diagnostic methods for the detection of rupture-      aneurysms: a pooled analysis of six prospective cohort studies. Lancet
           prone  IAs,  but  also  the  development  of  medical   Neurol 2014;13:59-66.
           therapy targeting macrophages. In the near future, the   7.   Yoshimura  Y,  Murakami  Y,  Saitoh  M,  Yokoi  T,  Aoki  T,  Miura  K,
                                                                 Ueshima H, Nozaki K. Statin use and risk of cerebral aneurysm rupture:
           diagnosis and treatment of unruptured IAs will enter a   a hospital-based case-control study in Japan. J Stroke Cerebrovasc Dis
           phase of major change. We hope that many patients     2014;23:343-8.
           with this disease will be more properly diagnosed and   8.   Tulamo R, Frosen J, Hernesniemi J, Niemela M. Inflammatory changes
           more safely treated.                                  in the aneurysm wall: a review. J Neurointerv Surg 2010;2:120-30.
                                                              9.   Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural
           Acknowledgments                                       fragility  and  inflammatory  response  of  ruptured  cerebral  aneurysms.
           Authors would like to express our sincere gratitude to   A  comparative  study  between  ruptured  and  unruptured  cerebral
                                                                 aneurysms. Stroke 1999;30:1396-401.
           all the researchers, collaborators, technical assistants   10.  Aoki  T,  Nishimura  M.  Targeting  chronic  inflammation  in  cerebral
           and secretaries contributing to our studies and also to   aneurysms:  focusing  on  NF-kappaB  as  a  putative  target  of  medical
           grants supporting our research work.                  therapy. Expert Opin Ther Targets 2010;14:265-73.
                                                              11.  Fukuda M, Aoki T. Molecular basis for intracranial aneurysm formation.
           Financial support and sponsorship                     Acta Neurochir Suppl 2015;120:13-5.
           T.A. is supported by the Coordination Fund from JST   12.  Aoki T, Narumiya S. Prostaglandins and chronic inflammation. Trends
           and Astellas Pharma Inc.                              Pharmacol Sci 2012;33:304-11.
                                                              13.  Aoki  T,  Kataoka  H,  Shimamura  M,  Nakagami  H,  Wakayama  K,
           Conflicts of interest                                 Moriwaki T, Ishibashi R, Nozaki K, Morishita R, Hashimoto N. NF-
                                                                 kappaB is a key mediator of cerebral aneurysm formation. Circulation
           There are no conflicts of interest.                   2007;116:2830-40.
                                                              14.  Frosen J, Piippo A, Paetau A, Kangasniemi M, Niemela M, Hernesniemi
           Patient consent                                       J, Jaaskelainen J. Remodeling of saccular cerebral artery aneurysm wall
           No patient involved.                                  is associated with rupture: histological analysis of 24 unruptured and 42
                                                                 ruptured cases. Stroke 2004;35:2287-93.
           Ethics approval                                    15.  Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial
           This article does not contain any studies with human   aneurysms. Neurosurgery 1999;45:1137-46.
           participants or animals.                           16.  Hasan D, Chalouhi N, Jabbour P, Hashimoto T. Macrophage imbalance
                                                                 (M1  vs.  M2)  and  upregulation  of  mast  cells  in  wall  of  ruptured
                                                                 human cerebral aneurysms: preliminary results. J Neuroinflammation
           REFERENCES                                            2012;9:222.
                                                              17.  Chu Y, Wilson K, Gu H, Wegman-Points L, Dooley SA, Pierce GL,
           1.   van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet   Cheng G, Pena Silva RA, Heistad DD, Hasan D. Myeloperoxidase is
               2007;369:306-18.                                  increased in  human  cerebral aneurysms  and increases  formation and
           2.   Morita  A,  Kirino  T,  Hashi  K,  Aoki  N,  Fukuhara  S,  Hashimoto  N,   rupture of cerebral aneurysms in mice. Stroke 2015;46:1651-6.
               Nakayama T,  Sakai  M, Teramoto A, Tominari  S, Yoshimoto T. The   18.  Faleiro  LC,  Machado  CR,  Gripp A  Jr.,  Resende  RA,  Rodrigues  PA.
               natural course of unruptured cerebral aneurysms in a Japanese cohort. N   Cerebral vasospasm: presence of mast cells in human cerebral arteries
               Engl J Med 2012;366:2474-82.                      after aneurysm rupture. J Neurosurg 1981;54:733-5.
           3.   Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small Unruptured   19.  Ollikainen E, Tulamo R, Frosen J, Lehti S, Honkanen P, Hernesniemi
               Intracranial Aneurysm Verification Study; SUAVe Study, Japan. Stroke   J,  Niemela  M,  Kovanen  PT.  Mast  cells,  neovascularization,  and
               2010;41:1969-77.                                  microhemorrhages  are  associated  with  saccular  intracranial  artery
           4.   Hokari M, Nakayama N, Nishihara H, Houkin K. Pathological findings   aneurysm wall remodeling. J Neuropathol Exp Neurol 2014;73:855-64.
               of saccular cerebral aneurysms-impact of subintimal fibrin deposition   20.  Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology
               on aneurysm rupture. Neurosurg Rev 2015;38:531-40; discussion 40.  eighth edition. In: editor editors, editor. PA: Elsevier Saunders;2014.
           5.   Etminan  N,  Brown  RJ,  Beseoglu  K,  Juvela  S,  Raymond  J,  Morita   21.  Zhang  HF,  Zhao  MG,  Liang  GB,  Yu  CY,  He  W,  Li  ZQ,  Gao  X.
            178                                                                   Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ August 31, 2016
   182   183   184   185   186   187   188   189   190   191   192